ACS Stock Overview
Offers healthcare services in Greece and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 1/6 |
Athens Medical C.S.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €1.37 |
| 52 Week High | €2.00 |
| 52 Week Low | €1.26 |
| Beta | 1.12 |
| 11 Month Change | 3.80% |
| 3 Month Change | -6.19% |
| 1 Year Change | -13.61% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 9.20% |
Recent News & Updates
Recent updates
Shareholder Returns
| ACS | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.5% | 0.1% | -0.02% |
| 1Y | -13.6% | 17.2% | 8.2% |
Return vs Industry: ACS underperformed the German Healthcare industry which returned 17.2% over the past year.
Return vs Market: ACS underperformed the German Market which returned 8.2% over the past year.
Price Volatility
| ACS volatility | |
|---|---|
| ACS Average Weekly Movement | 3.1% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: ACS has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: ACS's weekly volatility has decreased from 9% to 3% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1983 | 3,230 | Vasilios Apostolopoulos | www.iatriko.gr |
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and neuro- and spine surgery services. It also provides medical services for range of orthopedics, such as foot and ankle, hand and wrist, hip, knee, shoulder, and spine; sports injuries; plastic Surgeries for face, body, breast, obesity, reconstructive plastic surgery, scar correction, and sex reassignment; bariatric surgery for gastric banding, sleeve gastrectomy, and biliopancreatic diversion with duodenal switch; and chronic diseases, including diabetes, endocrinology, heat failure, high blood pressure, pain management, respiratory system, stroke, and thyroid conditions.
Athens Medical C.S.A. Fundamentals Summary
| ACS fundamental statistics | |
|---|---|
| Market cap | €133.57m |
| Earnings (TTM) | €9.07m |
| Revenue (TTM) | €249.37m |
14.7x
P/E Ratio0.5x
P/S RatioIs ACS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ACS income statement (TTM) | |
|---|---|
| Revenue | €249.37m |
| Cost of Revenue | €185.18m |
| Gross Profit | €64.19m |
| Other Expenses | €55.12m |
| Earnings | €9.07m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.10 |
| Gross Margin | 25.74% |
| Net Profit Margin | 3.64% |
| Debt/Equity Ratio | 124.8% |
How did ACS perform over the long term?
See historical performance and comparison